Identification of the cytochrome P450 isoforms involved in the O-demethylation of 4-nitroanisole in human liver microsomes

被引:30
作者
Jones, BC
Tyman, CA
Smith, DA
机构
[1] Department of Drug Metabolism, Pfizer Central Research
关键词
D O I
10.1080/004982597240000
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1. 4-Nitroanisole is O-demethylated to 4-nitrophenol by human liver microsomes. Kinetic studies indicate that this metabolic route is mediated by two cytochrome P450 isoforms, one with a K-m = 2.1 mu M and the other with a K-m = 220 mu M. 2. Chemical inhibition and correlation studies in human liver microsomes indicate that the low K-m enzyme is CYP2A6 and the high K-m enzyme is CYP2E1 suggesting that 4-nitroanisole is not a general cytochrome P450 substrate. 3. Studies using expressed recombinant cytochrome P450s indicated that all the cytochrome P450s investigated metabolized 4-nitroanisole but CYP2A6 and CYP2E1 produced the highest rates. Kinetic studies with these two isoforms produced a K-m for CYP2A6 of 9 mu M and 54 mu M for CYP2E1. 4. The involvement of these two isoforms in the O-demethylation of 4-nitroanisole can be rationalized in terms of a hydrogen bond interaction with the nitro group and the active site of CYP2A6 and a hydrophobic interaction with the active site of CYP2E1.
引用
收藏
页码:1025 / 1037
页数:13
相关论文
共 32 条
[1]   Validation of the (omega-1)-hydroxylation of lauric acid as an in vitro substrate probe for human liver CYP2E1 [J].
Amet, Y ;
Berthou, F ;
Baird, S ;
Dreano, Y ;
Bail, JP ;
Menez, JF .
BIOCHEMICAL PHARMACOLOGY, 1995, 50 (11) :1775-1782
[2]   KETOCONAZOLE AND SULFAPHENAZOLE AS THE RESPECTIVE SELECTIVE INHIBITORS OF P4503A AND 2C9 [J].
BALDWIN, SJ ;
BLOOMER, JC ;
SMITH, GJ ;
AYRTON, AD ;
CLARKE, SE ;
CHENERY, RJ .
XENOBIOTICA, 1995, 25 (03) :261-270
[3]   EFFECT OF E-5110, A NOVEL NONSTEROIDAL ANTIINFLAMMATORY DRUG, ON TRIMETHADIONE METABOLISM AS AN INDICATOR OF HEPATIC DRUG-OXIDIZING CAPACITY IN BEAGLE DOG [J].
DALING, Z ;
TANAKA, E ;
NAKAMURA, T ;
HORIE, T .
XENOBIOTICA, 1994, 24 (03) :215-220
[4]   Antipyrine as a probe for human oxidative drug metabolism: Identification of the cytochrome P450 enzymes catalyzing 4-hydroxyantipyrine, 3-hydromethylantipyrine, and norantipyrine formation [J].
Engel, G ;
Hofmann, U ;
Heidemann, H ;
Cosme, J ;
Eichelbaum, M .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1996, 59 (06) :613-623
[5]   PURIFICATION AND CHARACTERIZATION OF LIVER MICROSOMAL CYTOCHROME-P-450 FROM UNTREATED MALE-RATS [J].
FUNAE, Y ;
IMAOKA, S .
BIOCHIMICA ET BIOPHYSICA ACTA, 1987, 926 (03) :349-358
[6]   Inhibitory and non-inhibitory monoclonal antibodies to human cytochrome P450 3A3/4 [J].
Gelboin, HV ;
Krausz, KW ;
Goldfarb, I ;
Buters, JTM ;
Yang, SK ;
Gonzalez, FJ ;
Korzekwa, KR ;
Shou, MG .
BIOCHEMICAL PHARMACOLOGY, 1995, 50 (11) :1841-1850
[7]  
Gibson GG, 1986, INTRO DRUG METABOLIS
[8]   HUMAN CYTOCHROMES-P450 - PROBLEMS AND PROSPECTS [J].
GONZALEZ, FJ .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1992, 13 (09) :346-352
[9]  
HARGREAVES MB, 1994, DRUG METAB DISPOS, V22, P806
[10]  
IZUISHI K, 1995, JAPANESE KANZO, V36, P471